v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Total revenues $ 60,112 $ 32,704
Costs and expenses:    
Cost of sales 7,157 3,648
Research and development 41,725 36,973
Selling, general, and administrative 63,591 39,087
Total costs and expenses 112,473 79,708
Loss from operations (52,361) (47,004)
Other income (expense):    
Other income (expense), net (1,704) (644)
Interest expense (4,583) (5,409)
Interest income 3,554 3,639
Total other income (expense), net (2,733) (2,414)
Loss before income taxes (55,094) (49,418)
Provision for income taxes 545 80
Net loss (55,639) (49,498)
Accrued dividends on convertible preferred stock (1,104) (1,322)
Net loss attributable to common stockholders $ (56,743) $ (50,820)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.83) $ (0.81)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.83) $ (0.81)
Weighted-average common shares outstanding, basic (in shares) 67,974,193 63,059,165
Weighted-average common shares outstanding, diluted (in shares) 67,974,193 63,059,165
Other comprehensive income (loss):    
Net loss $ (56,743) $ (50,820)
Foreign currency translation adjustment 1,784 (2)
Unrealized gain (loss), net on marketable securities (544) (10)
Comprehensive loss (54,399) (50,832)
Product revenue, net    
Total revenues 60,112 37,718
License revenue    
Total revenues $ 0 $ (5,014)